Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.

@article{Giesbers1989RecurrenceOS,
  title={Recurrence of superficial bladder carcinoma after intravesical instillation of mitomycin-C. Comparison of exposure times.},
  author={A A Giesbers and P J van Helsdingen and Amy E. Kramer},
  journal={British journal of urology},
  year={1989},
  volume={63 2},
  pages={176-9}
}
A total of 70 patients were treated with intravesical instillations of Mitomycin-C (MMC) following transurethral resection for superficial bladder carcinoma. In this randomised prospective study the influence of 2 exposure times (0.5 and 1 h) was studied in relation to tumour recurrence, recurrence interval, tumour progression and toxicity. The number of patients with recurrent tumours was significantly lower in the 1-h group. Tumour progression was seen in only 2 patients in each group and all… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
A total of 70 patients were treated with intravesical instillations of Mitomycin - C ( MMC ) following transurethral resection for superficial bladder carcinoma .
A total of 70 patients were treated with intravesical instillations of Mitomycin - C ( MMC ) following transurethral resection for superficial bladder carcinoma .
A total of 70 patients were treated with intravesical instillations of Mitomycin - C ( MMC ) following transurethral resection for superficial bladder carcinoma .
Urinary BladderDirect superior toProstate
Tumour progression was seen in only 2 patients in each group and all had primary or secondary carcinoma in situ of the bladder or prostatic urethra .
Tumour progression was seen in only 2 patients in each group and all had primary or secondary carcinoma in situ of the bladder or prostatic urethra .
Tumour progression was seen in only 2 patients in each group and all had primary or secondary carcinoma in situ of the bladder or prostatic urethra .
Urinary BladderSibling in part ofProstate
Tumour progression was seen in only 2 patients in each group and all had primary or secondary carcinoma in situ of the bladder or prostatic urethra .
ProstateSibling in part ofUrinary Bladder
Tumour progression was seen in only 2 patients in each group and all had primary or secondary carcinoma in situ of the bladder or prostatic urethra .
Bladder NeoplasmMay be treated byMitomycin
A total of 70 patients were treated with intravesical instillations of Mitomycin - C ( MMC ) following transurethral resection for superficial bladder carcinoma .
A total of 70 patients were treated with intravesical instillations of Mitomycin - C ( MMC ) following transurethral resection for superficial bladder carcinoma .
A total of 70 patients were treated with intravesical instillations of Mitomycin - C ( MMC ) following transurethral resection for superficial bladder carcinoma .
A total of 70 patients were treated with intravesical instillations of Mitomycin - C ( MMC ) following transurethral resection for superficial bladder carcinoma .
All Topics